Show simple item record

dc.contributor.authorSletta, Kristine Yttersianen_US
dc.contributor.authorTveitarås, Maria Kathrineen_US
dc.contributor.authorLu, Ningen_US
dc.contributor.authorSvendsen, Agneteen_US
dc.contributor.authorReed, Rolf K.en_US
dc.contributor.authorGarmann-Johnsen, Annetteen_US
dc.contributor.authorStuhr, Linda Elin Birkhaugen_US
dc.date.accessioned2018-03-01T15:44:25Z
dc.date.available2018-03-01T15:44:25Z
dc.date.issued2017-08-23
dc.PublishedSletta KY, Tveitarås MK, Lu N, Svendsen A, Reed RK, Garmann-Johnsen A, Stuhr LEB. Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts. PLoS ONE. 2017;12(8):e0183254eng
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/1956/17450
dc.description.abstractBackground: Tumor hypoxia is relevant for tumor growth, metabolism, resistance to chemotherapy and metastasis. We have previously shown that hyperoxia, using hyperbaric oxygen treatment (HBOT), attenuates tumor growth and shifts the phenotype from mesenchymal to epithelial (MET) in the DMBA-induced mammary tumor model. This study describes the effect of HBOT on tumor growth, angiogenesis, chemotherapy efficacy and metastasis in a triple negative MDA-MB-231 breast cancer model, and evaluates tumor growth using a triple positive BT-474 breast cancer model. Materials and methods: 5 x 105 cancer cells were injected s.c. in the groin area of NOD/SCID female mice. The BT-474 group was supplied with Progesterone and Estradiol pellets 2-days prior to tumor cell injection. Mice were divided into controls (1 bar, pO2 = 0.2 bar) or HBOT (2.5 bar, pO2 = 2.5 bar, 90 min, every third day until termination of the experiments). Treatment effects were determined by assessment of tumor growth, proliferation (Ki67-staining), angiogenesis (CD31-staining), metastasis (immunostaining), EMT markers (western blot), stromal components collagen type I, Itgb1 and FSP1 (immunostaining) and chemotherapeutic efficacy (5FU). Results: HBOT significantly suppressed tumor growth in both the triple positive and negative tumors, and both MDA-MB-231 and BT-474 showed a decrease in proliferation after HBOT. No differences were found in angiogenesis or 5FU efficacy between HBOT and controls. Nevertheless, HBOT significantly reduced both numbers and total area of the metastastatic lesions, as well as reduced expression of N-cadherin, Axl and collagen type I measured in the MDA-MB-231 model. No change in stromal Itgb1 and FSP1 was found in either tumor model. Conclusion: Despite the fact that behavior and prognosis of the triple positive and negative subtypes of cancer are different, the HBOT had a similar suppressive effect on tumor growth, indicating that they share a common oxygen dependent anti-tumor mechanism. Furthermore, HBOT significantly reduced the number and area of metastatic lesions in the triple negative model as well as a significant reduction in the EMT markers N-cadherin, Axl and density of collagen type I.en_US
dc.language.isoengeng
dc.publisherPLOSeng
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0eng
dc.titleOxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenograftsen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2018-01-05T10:19:27Z
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2017 The Author(s)
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0183254
dc.identifier.cristin1509475
dc.source.journalPLoS ONE


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY